IHC and western blot analyses revealed that Erianin inhibited the expression of LKB1, SIK2, SIK3, and PARD3 in a dose-dependent manner in the mouse tumor tissues, and 5-FU also significantly reduced the levels of these proteins (Figure 7J,K). Here, PARD3 is linked to neoplasm.